Perspectives on translational molecular imaging and therapy: an overview of key questions to be addressed

Affiliations

• ¹ Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands. F.w.b.van_leeuwen@lumc.nl.
• ² Unit of Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
• ³ Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Aachen, Germany.
• ⁴ Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
• ⁵ Department of Nuclear Medicine, DMU IMAGINA, APHP, Hôpital Européen Georges-Pompidou, University of Paris, Paris, France.
• ⁶ PARCC, INSERM 690, Université de Paris, Paris, France.
• ⁷ Radiology and Molecular Imaging, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
• ⁸ Department of Medical Physics, Uppsala University Hospital, Uppsala, Sweden.
• ⁹ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
• ¹⁰ Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.
• ¹¹ Department of Radiology and Nuclear Medicine, Rijnstate Hospital Arnhem, Arnhem, The Netherlands.
• ¹² Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.